Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 002199.SZ
Valuation Weak
14%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Bad
0%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -7.19 1.35 1.45
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -41.05 -8.34 -5.91
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -5.89 1.17 1.24
Cash -2.90 0.23 0.23
Capex 93.74 < 0.005 -0.01
Free Cash Flow -45.45 < 0.005 -0.01
Revenue -8.24 0.18 0.19
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -73.51 0.03 -0.13
Operating Margin 12.86 -0.42 -0.48
ROA 20.59 -0.04 -0.04
ROE 17.55 -0.06 -0.08
ROIC 2.60 -0.05 -0.05
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 002199.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 002199.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 002199.SZ is permitted for members.